|
|||||||||||||||||||||
|
|||||||||||||||||||||
Issue: September 2023 Volume 8 | Issue 9 Review Result and Publication of Paper within : 2-3 days Click Here For more DetailsFor Authors Forms / Download Published Issue Details Editorial Board Other IMP Links Facts & Figure Impact Factor : 8.76 Issue per Year : 12 Volume Published : 8 Issue Published : 88 Article Submitted : 26066 Article Published : 7438 Total Authors : 18836 Total Reviewer : 971 Total Countries : 150 Indexing Partner Join RMS/Earn 300 Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Disclaimer
By using this site, its content, and information you agree to assume all risks associated with your use or transfer of information. You agree to hold the IJNRD.org harmless from any claims relating to the use of this site. IJNRD.org comes without warranty of any kind. We do not warrant that the site will operate correctly or that the site or its server is free of computer viruses or other harmful devices. Use at your own risk. In no event shall we be liable for any use of the IJNRD.org website or information derived thereof. I do not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information disclosed in IJNRD.org .
Although every effort is made to ensure the correctness of information submitted for publication, the website may inadvertently contain technical inaccuracies or typographical errors. Information may be changed or updated without notice. IJNRD.org may also make improvements and/or changes related to publication methods and the other related data described in this information at any time without notice. IJNRD.org assumes no responsibility for errors or omissions in this publication or other documents that are referenced by or linked to this publication.
|
ISSN Details
ISSN: 2456-4184 DOI (A digital object identifier) Conference Open Access License Policy Important Details Social Media |
|||||||||||||||||||
|
Facebook Twitter Instagram LinkedIn